The Effect of Food on the Bioavailability of Norethindrone and Ethinyl Estradiol from Norethindrone Acetate/Ethinyl Estradiol Tablets Intended for Continuous Hormone Replacement Therapy

@article{Boyd2003TheEO,
  title={The Effect of Food on the Bioavailability of Norethindrone and Ethinyl Estradiol from Norethindrone Acetate/Ethinyl Estradiol Tablets Intended for Continuous Hormone Replacement Therapy},
  author={R. Boyd and E. A. Zegarac and M. Eldon},
  journal={The Journal of Clinical Pharmacology},
  year={2003},
  volume={43}
}
  • R. Boyd, E. A. Zegarac, M. Eldon
  • Published 2003
  • Chemistry, Medicine
  • The Journal of Clinical Pharmacology
  • As part of the development of a combination product containing norethindrone acetate and low‐dose ethinyl estradiol for continuous hormone replacement therapy in postmenopausal women, a study was conducted to determine the effect of a high‐fat meal on the bioavailability of norethindrone and ethinyl estradiol from tablets containing 1 mg norethindrone acetate/10 μg ethinyl estradiol. Eighteen healthy postmenopausal women participated in an open‐label, single‐dose, randomized, three‐way… CONTINUE READING
    21 Citations
    Pharmacology of estrogens and progestogens: influence of different routes of administration
    • H. Kuhl
    • Medicine
    • Climacteric : the journal of the International Menopause Society
    • 2005
    • 436
    • PDF
    Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: A review of the data and identification of knowledge gaps
    • 41
    • PDF

    References

    SHOWING 1-10 OF 24 REFERENCES
    Kinetics of norethindrone in women; II. Single‐dose kinetics
    • 74
    Identification and measurement by gas chromatography-mass spectrometry of norethindrone and metabolites in human urine and blood.
    • 47
    Pharmacokinetics of norethindrone: effect of particle size.
    • 8
    Can grapefruit juice influence ethinylestradiol bioavailability?
    • 81
    Influence of absorbable and nonabsorbable lipids and lipidlike substances on drug bioavailability
    • 31